12-80320508-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001378609.3(OTOGL):c.3889T>C(p.Trp1297Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000162 in 1,613,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar.
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 84BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTOGL | NM_001378609.3 | c.3889T>C | p.Trp1297Arg | missense_variant | Exon 34 of 59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000406 AC: 10AN: 246410 AF XY: 0.0000448 show subpopulations
GnomAD4 exome AF: 0.000164 AC: 240AN: 1461372Hom.: 0 Cov.: 31 AF XY: 0.000127 AC XY: 92AN XY: 726960 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 1288 of the OTOGL protein (p.Trp1288Arg). This variant is present in population databases (rs148064564, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with OTOGL-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Inborn genetic diseases Uncertain:1
The c.3862T>C (p.W1288R) alteration is located in exon 33 (coding exon 33) of the OTOGL gene. This alteration results from a T to C substitution at nucleotide position 3862, causing the tryptophan (W) at amino acid position 1288 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at